Syddansk Universitet Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells

[1]  S. Rosenberg,et al.  Prospects for gene-engineered T cell immunotherapy for solid cancers , 2016, Nature Medicine.

[2]  T. Schumacher,et al.  Neoantigens in cancer immunotherapy , 2015, Science.

[3]  Sadik H. Kassim,et al.  A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response , 2014, Clinical Cancer Research.

[4]  P. Greenberg,et al.  Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells , 2014, Nature Protocols.

[5]  C. Batt,et al.  Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer , 2014, Cancer Immunology Research.

[6]  Adam Bagg,et al.  Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. , 2013, Blood.

[7]  A. Giobbie-Hurder,et al.  Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional Measurements , 2013, Clinical Cancer Research.

[8]  Bernd Hauck,et al.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.

[9]  K. Steinbrink,et al.  Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells , 2013, Front. Immunol..

[10]  Tongguang Wang,et al.  Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy , 2013, Journal of immunotherapy.

[11]  C. Klebanoff,et al.  Paths to stemness: building the ultimate antitumour T cell , 2012, Nature Reviews Cancer.

[12]  D. Powell,et al.  Pro-survival signaling via CD27 costimulation drives effective CAR T-cell therapy , 2012, Oncoimmunology.

[13]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[14]  B. Ursø,et al.  Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A , 2012, PloS one.

[15]  Lewis L. Lanier,et al.  NK cell development, homeostasis and function: parallels with CD8+ T cells , 2011, Nature Reviews Immunology.

[16]  A. Bagg,et al.  Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. , 2011, The New England journal of medicine.

[17]  A. Nakao,et al.  CD70 is selectively expressed on Th1 but not on Th2 cells and is required for Th1-type immune responses. , 2011, The Journal of investigative dermatology.

[18]  P. Rougé,et al.  A case of severe anaphylaxis to kidney bean: phaseolin (vicilin) and PHA (lectin) identified as putative allergens , 2011, Allergy.

[19]  P. Vyas,et al.  Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. , 2010, Blood.

[20]  M. Albert,et al.  Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. , 2010, Blood.

[21]  A. Loriot,et al.  DNA hypomethylation in cancer: Epigenetic scars of a neoplastic journey , 2010, Epigenetics.

[22]  S. Rosenberg,et al.  Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. , 2009, Blood.

[23]  R. Hynes,et al.  Natural killer cells require selectins for suppression of subcutaneous tumors. , 2009, Cancer research.

[24]  J. Vicente-Carbajosa,et al.  DNA-free RNA isolation protocols for Arabidopsis thaliana, including seeds and siliques , 2008, BMC research notes.

[25]  Mike Gough,et al.  Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. , 2008, The Journal of clinical investigation.

[26]  G. Rabinovich,et al.  Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.

[27]  S. Rosenberg,et al.  Modulation by IL-2 of CD70 and CD27 Expression on CD8+ T Cells: Importance for the Therapeutic Effectiveness of Cell Transfer Immunotherapy1 , 2006, The Journal of Immunology.

[28]  Jean-Philippe Brunet,et al.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation , 2005, Nature Genetics.

[29]  Victor V Lobanenkov,et al.  Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. , 2005, Cancer research.

[30]  Lloyd J. Old,et al.  Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.

[31]  T. Waldmann,et al.  Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  S. Rosenberg,et al.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. , 2005, The Journal of clinical investigation.

[33]  P. Kleihues,et al.  Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.

[34]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[35]  A. Jeltsch,et al.  Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy , 2004, Cancer biology & therapy.

[36]  D. Berd,et al.  Whole cell ELISA for detection of tumor antigen expression in tumor samples. , 2001, Journal of immunological methods.

[37]  P. Guldberg,et al.  Methylation-dependent Silencing of the Reduced Folate Carrier Gene in Inherently Methotrexate-resistant Human Breast Cancer Cells* , 2001, The Journal of Biological Chemistry.

[38]  P. Guldberg,et al.  In-tube DNA methylation profiling by fluorescence melting curve analysis. , 2001, Clinical chemistry.

[39]  S. Salvi,et al.  Anti‐MAGE‐3 antibody 57b and anti‐MAGE‐1 antibody 6C1 can be used to study different proteins of the MAGE‐A family , 2000, International journal of cancer.

[40]  J. Zeuthen,et al.  Establishment of gp100 and MART-1/Melan-A-specific cytotoxic T lymphocyte clones using in vitro immunization against preselected highly immunogenic melanoma cell clones , 1999, Cancer Immunology, Immunotherapy.

[41]  G. Schuler,et al.  Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. , 1999, Journal of immunological methods.

[42]  P. Guldberg,et al.  Detection and Characterization of αβ-T-Cell Clonality by Denaturing Gradient Gel Electrophoresis (DGGE) , 1998 .

[43]  J. Zeuthen,et al.  Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines , 1997, International journal of cancer.

[44]  O. de Backer,et al.  The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Shichijo,et al.  Induction of MAGE Genes in Lymphoid Cells by the Demethylating Agent 5‐Aza‐2′‐deoxycytidine , 1996, Japanese journal of cancer research : Gann.

[46]  K. Ley,et al.  Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. , 1994, Immunity.

[47]  M. Herlyn,et al.  Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine. , 1994, Cancer research.

[48]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[49]  B. Richardson,et al.  Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4+ cells. , 1986, Human immunology.

[50]  T. Eberlein.  Durable Complete Responses in Heavily Pretreated Patients with metastatic Melanoma Using T-Cell Transfer Immunotherapy , 2012 .

[51]  B. Weinert,et al.  Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine. , 2009, Cancer immunity.

[52]  直田 浩明.  Generation of peptide-specific CD8[+] T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4[+] T cells , 2006 .

[53]  P. Romero,et al.  Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma. , 2001, Cancer research.